Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer S. HohausS. MartinR. Haas ORIGINAL ARTICLE Pages: S13 - S17
Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy F. LoboA. FrauL. G. Estévez ORIGINAL ARTICLE Pages: S5 - S8
Dose-intense salvage therapy after neoadjuvant chemotherapy: feasibility and preliminary results T. PalangiéJ. Y. PiergaP. Pouillart ORIGINAL ARTICLE Pages: S24 - S25
Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma S. CliveJ. GardinerR. C. F. Leonard ORIGINAL ARTICLE Pages: S29 - S30
Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I–II clinical trial C. CampisiA. FabiF. Cognetti ORIGINAL ARTICLE Pages: S1 - S4
FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the `out-patient' setting N. G. P. DavidsonA. S. DavisP. D. Cheverton ORIGINAL ARTICLE Pages: S18 - S23
Ifosfamide and vinorelbine in metastatic breast cancer in patients with prior anthracycline therapy Z. AzizA. RehmanS. Qazi ORIGINAL ARTICLE Pages: S9 - S12
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer A. Y. ChangL. HuiJ. Rubins ORIGINAL ARTICLE Pages: S26 - S28